United States Osteoarthritis Pain Drugs Market Report & Forecast 2021-2027

United States Osteoarthritis Pain Drugs Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Osteoarthritis Pain Drugs Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Osteoarthritis Pain Drugs Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Osteoarthritis Pain Drugs Overall Market Size
2.1 United States Osteoarthritis Pain Drugs Market Size: 2021 VS 2027
2.2 United States Osteoarthritis Pain Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Osteoarthritis Pain Drugs Sales: 2016-2027
3 Company Landscape
3.1 Top Osteoarthritis Pain Drugs Players in United States Market
3.2 Top United States Osteoarthritis Pain Drugs Companies Ranked by Revenue
3.3 United States Osteoarthritis Pain Drugs Revenue by Companies
3.4 United States Osteoarthritis Pain Drugs Sales by Companies
3.5 United States Osteoarthritis Pain Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Osteoarthritis Pain Drugs Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Osteoarthritis Pain Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Osteoarthritis Pain Drugs Players in United States Market
3.8.1 List of Tier 1 Osteoarthritis Pain Drugs Companies in United States
3.8.2 List of Tier 2 and Tier 3 Osteoarthritis Pain Drugs Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Osteoarthritis Pain Drugs Market Size Markets, 2021 & 2027
4.1.2 Oral
4.1.3 Injection
4.1.4 External
4.2 By Type - United States Osteoarthritis Pain Drugs Revenue & Forecasts
4.2.1 By Type - United States Osteoarthritis Pain Drugs Revenue, 2016-2021
4.2.2 By Type - United States Osteoarthritis Pain Drugs Revenue, 2022-2027
4.2.3 By Type - United States Osteoarthritis Pain Drugs Revenue Market Share, 2016-2027
4.3 By Type - United States Osteoarthritis Pain Drugs Sales & Forecasts
4.3.1 By Type - United States Osteoarthritis Pain Drugs Sales, 2016-2021
4.3.2 By Type - United States Osteoarthritis Pain Drugs Sales, 2022-2027
4.3.3 By Type - United States Osteoarthritis Pain Drugs Sales Market Share, 2016-2027
4.4 By Type - United States Osteoarthritis Pain Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Osteoarthritis Pain Drugs Market Size, 2021 & 2027
5.1.2 Medical Care
5.1.3 Personal Care
5.2 By Application - United States Osteoarthritis Pain Drugs Revenue & Forecasts
5.2.1 By Application - United States Osteoarthritis Pain Drugs Revenue, 2016-2021
5.2.2 By Application - United States Osteoarthritis Pain Drugs Revenue, 2022-2027
5.2.3 By Application - United States Osteoarthritis Pain Drugs Revenue Market Share, 2016-2027
5.3 By Application - United States Osteoarthritis Pain Drugs Sales & Forecasts
5.3.1 By Application - United States Osteoarthritis Pain Drugs Sales, 2016-2021
5.3.2 By Application - United States Osteoarthritis Pain Drugs Sales, 2022-2027
5.3.3 By Application - United States Osteoarthritis Pain Drugs Sales Market Share, 2016-2027
5.4 By Application - United States Osteoarthritis Pain Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Overview
6.1.3 Pfizer Osteoarthritis Pain Drugs Sales and Revenue in United States Market (2016-2021)
6.1.4 Pfizer Osteoarthritis Pain Drugs Product Description
6.1.5 Pfizer Recent Developments
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Overview
6.2.3 Bayer Osteoarthritis Pain Drugs Sales and Revenue in United States Market (2016-2021)
6.2.4 Bayer Osteoarthritis Pain Drugs Product Description
6.2.5 Bayer Recent Developments
6.3 SK Chemicals
6.3.1 SK Chemicals Corporation Information
6.3.2 SK Chemicals Overview
6.3.3 SK Chemicals Osteoarthritis Pain Drugs Sales and Revenue in United States Market (2016-2021)
6.3.4 SK Chemicals Osteoarthritis Pain Drugs Product Description
6.3.5 SK Chemicals Recent Developments
6.4 GSK
6.4.1 GSK Corporation Information
6.4.2 GSK Overview
6.4.3 GSK Osteoarthritis Pain Drugs Sales and Revenue in United States Market (2016-2021)
6.4.4 GSK Osteoarthritis Pain Drugs Product Description
6.4.5 GSK Recent Developments
6.5 Sanofi
6.5.1 Sanofi Corporation Information
6.5.2 Sanofi Overview
6.5.3 Sanofi Osteoarthritis Pain Drugs Sales and Revenue in United States Market (2016-2021)
6.5.4 Sanofi Osteoarthritis Pain Drugs Product Description
6.5.5 Sanofi Recent Developments
6.6 Crystal Genomics
6.6.1 Crystal Genomics Corporation Information
6.6.2 Crystal Genomics Overview
6.6.3 Crystal Genomics Osteoarthritis Pain Drugs Sales and Revenue in United States Market (2016-2021)
6.6.4 Crystal Genomics Osteoarthritis Pain Drugs Product Description
6.6.5 Crystal Genomics Recent Developments
6.7 Johnson & Johnson
6.7.1 Johnson & Johnson Corporation Information
6.7.2 Johnson & Johnson Overview
6.7.3 Johnson & Johnson Osteoarthritis Pain Drugs Sales and Revenue in United States Market (2016-2021)
6.7.4 Johnson & Johnson Osteoarthritis Pain Drugs Product Description
6.7.5 Johnson & Johnson Recent Developments
6.8 Sino Biopharmaceutical
6.8.1 Sino Biopharmaceutical Corporation Information
6.8.2 Sino Biopharmaceutical Overview
6.8.3 Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales and Revenue in United States Market (2016-2021)
6.8.4 Sino Biopharmaceutical Osteoarthritis Pain Drugs Product Description
6.8.5 Sino Biopharmaceutical Recent Developments
6.9 Haohai Biological
6.9.1 Haohai Biological Corporation Information
6.9.2 Haohai Biological Overview
6.9.3 Haohai Biological Osteoarthritis Pain Drugs Sales and Revenue in United States Market (2016-2021)
6.9.4 Haohai Biological Osteoarthritis Pain Drugs Product Description
6.9.5 Haohai Biological Recent Developments
6.10 Zhejiang Chengyi Pharmaceutical
6.10.1 Zhejiang Chengyi Pharmaceutical Corporation Information
6.10.2 Zhejiang Chengyi Pharmaceutical Overview
6.10.3 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales and Revenue in United States Market (2016-2021)
6.10.4 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product Description
6.10.5 Zhejiang Chengyi Pharmaceutical Recent Developments
6.11 Freda
6.11.1 Freda Corporation Information
6.11.2 Freda Overview
6.11.3 Freda Osteoarthritis Pain Drugs Sales and Revenue in United States Market (2016-2021)
6.11.4 Freda Osteoarthritis Pain Drugs Product Description
6.11.5 Freda Recent Developments
6.12 Bright Future
6.12.1 Bright Future Corporation Information
6.12.2 Bright Future Overview
6.12.3 Bright Future Osteoarthritis Pain Drugs Sales and Revenue in United States Market (2016-2021)
6.12.4 Bright Future Osteoarthritis Pain Drugs Product Description
6.12.5 Bright Future Recent Developments
6.13 Jingfeng Pharmaceutical
6.13.1 Jingfeng Pharmaceutical Corporation Information
6.13.2 Jingfeng Pharmaceutical Overview
6.13.3 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales and Revenue in United States Market (2016-2021)
6.13.4 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Product Description
6.13.5 Jingfeng Pharmaceutical Recent Developments
6.14 Chugai Pharmaceutical
6.14.1 Chugai Pharmaceutical Corporation Information
6.14.2 Chugai Pharmaceutical Overview
6.14.3 Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales and Revenue in United States Market (2016-2021)
6.14.4 Chugai Pharmaceutical Osteoarthritis Pain Drugs Product Description
6.14.5 Chugai Pharmaceutical Recent Developments
6.15 Mikasa Seiyaku
6.15.1 Mikasa Seiyaku Corporation Information
6.15.2 Mikasa Seiyaku Overview
6.15.3 Mikasa Seiyaku Osteoarthritis Pain Drugs Sales and Revenue in United States Market (2016-2021)
6.15.4 Mikasa Seiyaku Osteoarthritis Pain Drugs Product Description
6.15.5 Mikasa Seiyaku Recent Developments
6.16 Taisho Pharmaceutical
6.16.1 Taisho Pharmaceutical Corporation Information
6.16.2 Taisho Pharmaceutical Overview
6.16.3 Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales and Revenue in United States Market (2016-2021)
6.16.4 Taisho Pharmaceutical Osteoarthritis Pain Drugs Product Description
6.16.5 Taisho Pharmaceutical Recent Developments
6.17 Seikagaku Corporation
6.17.1 Seikagaku Corporation Corporation Information
6.17.2 Seikagaku Corporation Overview
6.17.3 Seikagaku Corporation Osteoarthritis Pain Drugs Sales and Revenue in United States Market (2016-2021)
6.17.4 Seikagaku Corporation Osteoarthritis Pain Drugs Product Description
6.17.5 Seikagaku Corporation Recent Developments
6.18 GlaxoSmithKline
6.18.1 GlaxoSmithKline Corporation Information
6.18.2 GlaxoSmithKline Overview
6.18.3 GlaxoSmithKline Osteoarthritis Pain Drugs Sales and Revenue in United States Market (2016-2021)
6.18.4 GlaxoSmithKline Osteoarthritis Pain Drugs Product Description
6.18.5 GlaxoSmithKline Recent Developments
6.19 Eli Lilly
6.19.1 Eli Lilly Corporation Information
6.19.2 Eli Lilly Overview
6.19.3 Eli Lilly Osteoarthritis Pain Drugs Sales and Revenue in United States Market (2016-2021)
6.19.4 Eli Lilly Osteoarthritis Pain Drugs Product Description
6.19.5 Eli Lilly Recent Developments
6.20 Novartis
6.20.1 Novartis Corporation Information
6.20.2 Novartis Overview
6.20.3 Novartis Osteoarthritis Pain Drugs Sales and Revenue in United States Market (2016-2021)
6.20.4 Novartis Osteoarthritis Pain Drugs Product Description
6.20.5 Novartis Recent Developments
6.21 Horizon Pharma
6.21.1 Horizon Pharma Corporation Information
6.21.2 Horizon Pharma Overview
6.21.3 Horizon Pharma Osteoarthritis Pain Drugs Sales and Revenue in United States Market (2016-2021)
6.21.4 Horizon Pharma Osteoarthritis Pain Drugs Product Description
6.21.5 Horizon Pharma Recent Developments
6.22 Abbott
6.22.1 Abbott Corporation Information
6.22.2 Abbott Overview
6.22.3 Abbott Osteoarthritis Pain Drugs Sales and Revenue in United States Market (2016-2021)
6.22.4 Abbott Osteoarthritis Pain Drugs Product Description
6.22.5 Abbott Recent Developments
6.23 Mylan
6.23.1 Mylan Corporation Information
6.23.2 Mylan Overview
6.23.3 Mylan Osteoarthritis Pain Drugs Sales and Revenue in United States Market (2016-2021)
6.23.4 Mylan Osteoarthritis Pain Drugs Product Description
6.23.5 Mylan Recent Developments
6.24 Daiichi Sankyo
6.24.1 Daiichi Sankyo Corporation Information
6.24.2 Daiichi Sankyo Overview
6.24.3 Daiichi Sankyo Osteoarthritis Pain Drugs Sales and Revenue in United States Market (2016-2021)
6.24.4 Daiichi Sankyo Osteoarthritis Pain Drugs Product Description
6.24.5 Daiichi Sankyo Recent Developments
6.25 TEVA
6.25.1 TEVA Corporation Information
6.25.2 TEVA Overview
6.25.3 TEVA Osteoarthritis Pain Drugs Sales and Revenue in United States Market (2016-2021)
6.25.4 TEVA Osteoarthritis Pain Drugs Product Description
6.25.5 TEVA Recent Developments
6.26 Almatica Pharma
6.26.1 Almatica Pharma Corporation Information
6.26.2 Almatica Pharma Overview
6.26.3 Almatica Pharma Osteoarthritis Pain Drugs Sales and Revenue in United States Market (2016-2021)
6.26.4 Almatica Pharma Osteoarthritis Pain Drugs Product Description
6.26.5 Almatica Pharma Recent Developments
6.27 Astellas Pharma
6.27.1 Astellas Pharma Corporation Information
6.27.2 Astellas Pharma Overview
6.27.3 Astellas Pharma Osteoarthritis Pain Drugs Sales and Revenue in United States Market (2016-2021)
6.27.4 Astellas Pharma Osteoarthritis Pain Drugs Product Description
6.27.5 Astellas Pharma Recent Developments
6.28 Tide Pharmaceutical
6.28.1 Tide Pharmaceutical Corporation Information
6.28.2 Tide Pharmaceutical Overview
6.28.3 Tide Pharmaceutical Osteoarthritis Pain Drugs Sales and Revenue in United States Market (2016-2021)
6.28.4 Tide Pharmaceutical Osteoarthritis Pain Drugs Product Description
6.28.5 Tide Pharmaceutical Recent Developments
6.29 Iroko Pharmaceuticals
6.29.1 Iroko Pharmaceuticals Corporation Information
6.29.2 Iroko Pharmaceuticals Overview
6.29.3 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales and Revenue in United States Market (2016-2021)
6.29.4 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product Description
6.29.5 Iroko Pharmaceuticals Recent Developments
6.30 Hengrui Pharmaceutical
6.30.1 Hengrui Pharmaceutical Corporation Information
6.30.2 Hengrui Pharmaceutical Overview
6.30.3 Hengrui Pharmaceutical Osteoarthritis Pain Drugs Sales and Revenue in United States Market (2016-2021)
6.30.4 Hengrui Pharmaceutical Osteoarthritis Pain Drugs Product Description
6.30.5 Hengrui Pharmaceutical Recent Developments
7 United States Osteoarthritis Pain Drugs Production Capacity, Analysis
7.1 United States Osteoarthritis Pain Drugs Production Capacity, 2016-2027
7.2 Osteoarthritis Pain Drugs Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Osteoarthritis Pain Drugs Supply Chain Analysis
9.1 Osteoarthritis Pain Drugs Industry Value Chain
9.2 Osteoarthritis Pain Drugs Upstream Market
9.3 Osteoarthritis Pain Drugs Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Osteoarthritis Pain Drugs Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Osteoarthritis Pain Drugs in United States Market
Table 2. Top Osteoarthritis Pain Drugs Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Osteoarthritis Pain Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Osteoarthritis Pain Drugs Revenue Share by Companies, 2016-2021
Table 5. United States Osteoarthritis Pain Drugs Sales by Companies, (M Dose), 2016-2021
Table 6. United States Osteoarthritis Pain Drugs Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Osteoarthritis Pain Drugs Price (2016-2021) & (US$/Dose)
Table 8. Manufacturers Osteoarthritis Pain Drugs Product Type
Table 9. List of Tier 1 Osteoarthritis Pain Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Osteoarthritis Pain Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Oral
Table 12. Major Manufacturers of Injection
Table 13. By Type - United States Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Osteoarthritis Pain Drugs Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Osteoarthritis Pain Drugs Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Osteoarthritis Pain Drugs Sales (M Dose), 2016-2021
Table 17. By Type - United States Osteoarthritis Pain Drugs Sales (M Dose), 2022-2027
Table 18. By Application - United States Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Osteoarthritis Pain Drugs Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Osteoarthritis Pain Drugs Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Osteoarthritis Pain Drugs Sales (M Dose), 2016-2021
Table 22. By Application - United States Osteoarthritis Pain Drugs Sales (M Dose), 2022-2027
Table 23. Pfizer Corporation Information
Table 24. Pfizer Description and Major Businesses
Table 25. Pfizer Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 26. Pfizer Osteoarthritis Pain Drugs Product
Table 27. Pfizer Recent Developments
Table 28. Bayer Corporation Information
Table 29. Bayer Description and Major Businesses
Table 30. Bayer Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 31. Bayer Osteoarthritis Pain Drugs Product
Table 32. Bayer Recent Developments
Table 33. SK Chemicals Corporation Information
Table 34. SK Chemicals Description and Major Businesses
Table 35. SK Chemicals Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 36. SK Chemicals Osteoarthritis Pain Drugs Product
Table 37. SK Chemicals Recent Developments
Table 38. GSK Corporation Information
Table 39. GSK Description and Major Businesses
Table 40. GSK Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 41. GSK Osteoarthritis Pain Drugs Product
Table 42. GSK Recent Developments
Table 43. Sanofi Corporation Information
Table 44. Sanofi Description and Major Businesses
Table 45. Sanofi Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 46. Sanofi Osteoarthritis Pain Drugs Product
Table 47. Sanofi Recent Developments
Table 48. Crystal Genomics Corporation Information
Table 49. Crystal Genomics Description and Major Businesses
Table 50. Crystal Genomics Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 51. Crystal Genomics Osteoarthritis Pain Drugs Product
Table 52. Crystal Genomics Recent Developments
Table 53. Johnson & Johnson Corporation Information
Table 54. Johnson & Johnson Description and Major Businesses
Table 55. Johnson & Johnson Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 56. Johnson & Johnson Osteoarthritis Pain Drugs Product
Table 57. Johnson & Johnson Recent Developments
Table 58. Sino Biopharmaceutical Corporation Information
Table 59. Sino Biopharmaceutical Description and Major Businesses
Table 60. Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 61. Sino Biopharmaceutical Osteoarthritis Pain Drugs Product
Table 62. Sino Biopharmaceutical Recent Developments
Table 63. Haohai Biological Corporation Information
Table 64. Haohai Biological Description and Major Businesses
Table 65. Haohai Biological Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 66. Haohai Biological Osteoarthritis Pain Drugs Product
Table 67. Haohai Biological Recent Developments
Table 68. Zhejiang Chengyi Pharmaceutical Corporation Information
Table 69. Zhejiang Chengyi Pharmaceutical Description and Major Businesses
Table 70. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 71. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product
Table 72. Zhejiang Chengyi Pharmaceutical Recent Developments
Table 73. Freda Corporation Information
Table 74. Freda Description and Major Businesses
Table 75. Freda Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 76. Freda Osteoarthritis Pain Drugs Product
Table 77. Freda Recent Developments
Table 78. Bright Future Corporation Information
Table 79. Bright Future Description and Major Businesses
Table 80. Bright Future Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 81. Bright Future Osteoarthritis Pain Drugs Product
Table 82. Bright Future Recent Developments
Table 83. Jingfeng Pharmaceutical Corporation Information
Table 84. Jingfeng Pharmaceutical Description and Major Businesses
Table 85. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 86. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Product
Table 87. Jingfeng Pharmaceutical Recent Developments
Table 88. Chugai Pharmaceutical Corporation Information
Table 89. Chugai Pharmaceutical Description and Major Businesses
Table 90. Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 91. Chugai Pharmaceutical Osteoarthritis Pain Drugs Product
Table 92. Chugai Pharmaceutical Recent Developments
Table 93. Mikasa Seiyaku Corporation Information
Table 94. Mikasa Seiyaku Description and Major Businesses
Table 95. Mikasa Seiyaku Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 96. Mikasa Seiyaku Osteoarthritis Pain Drugs Product
Table 97. Mikasa Seiyaku Recent Developments
Table 98. Taisho Pharmaceutical Corporation Information
Table 99. Taisho Pharmaceutical Description and Major Businesses
Table 100. Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 101. Taisho Pharmaceutical Osteoarthritis Pain Drugs Product
Table 102. Taisho Pharmaceutical Recent Developments
Table 103. Seikagaku Corporation Corporation Information
Table 104. Seikagaku Corporation Description and Major Businesses
Table 105. Seikagaku Corporation Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 106. Seikagaku Corporation Osteoarthritis Pain Drugs Product
Table 107. Seikagaku Corporation Recent Developments
Table 108. GlaxoSmithKline Corporation Information
Table 109. GlaxoSmithKline Description and Major Businesses
Table 110. GlaxoSmithKline Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 111. GlaxoSmithKline Osteoarthritis Pain Drugs Product
Table 112. GlaxoSmithKline Recent Developments
Table 113. Eli Lilly Corporation Information
Table 114. Eli Lilly Description and Major Businesses
Table 115. Eli Lilly Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 116. Eli Lilly Osteoarthritis Pain Drugs Product
Table 117. Eli Lilly Recent Developments
Table 118. Novartis Corporation Information
Table 119. Novartis Description and Major Businesses
Table 120. Novartis Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 121. Novartis Osteoarthritis Pain Drugs Product
Table 122. Novartis Recent Developments
Table 123. Horizon Pharma Corporation Information
Table 124. Horizon Pharma Description and Major Businesses
Table 125. Horizon Pharma Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 126. Horizon Pharma Osteoarthritis Pain Drugs Product
Table 127. Horizon Pharma Recent Developments
Table 128. Abbott Corporation Information
Table 129. Abbott Description and Major Businesses
Table 130. Abbott Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 131. Abbott Osteoarthritis Pain Drugs Product
Table 132. Abbott Recent Developments
Table 133. Mylan Corporation Information
Table 134. Mylan Description and Major Businesses
Table 135. Mylan Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 136. Mylan Osteoarthritis Pain Drugs Product
Table 137. Mylan Recent Developments
Table 138. Daiichi Sankyo Corporation Information
Table 139. Daiichi Sankyo Description and Major Businesses
Table 140. Daiichi Sankyo Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 141. Daiichi Sankyo Osteoarthritis Pain Drugs Product
Table 142. Daiichi Sankyo Recent Developments
Table 143. TEVA Corporation Information
Table 144. TEVA Description and Major Businesses
Table 145. TEVA Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 146. TEVA Osteoarthritis Pain Drugs Product
Table 147. TEVA Recent Developments
Table 148. Almatica Pharma Corporation Information
Table 149. Almatica Pharma Description and Major Businesses
Table 150. Almatica Pharma Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 151. Almatica Pharma Osteoarthritis Pain Drugs Product
Table 152. Almatica Pharma Recent Developments
Table 153. Astellas Pharma Corporation Information
Table 154. Astellas Pharma Description and Major Businesses
Table 155. Astellas Pharma Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 156. Astellas Pharma Osteoarthritis Pain Drugs Product
Table 157. Astellas Pharma Recent Developments
Table 158. Tide Pharmaceutical Corporation Information
Table 159. Tide Pharmaceutical Description and Major Businesses
Table 160. Tide Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 161. Tide Pharmaceutical Osteoarthritis Pain Drugs Product
Table 162. Tide Pharmaceutical Recent Developments
Table 163. Iroko Pharmaceuticals Corporation Information
Table 164. Iroko Pharmaceuticals Description and Major Businesses
Table 165. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 166. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product
Table 167. Iroko Pharmaceuticals Recent Developments
Table 168. Hengrui Pharmaceutical Corporation Information
Table 169. Hengrui Pharmaceutical Description and Major Businesses
Table 170. Hengrui Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 171. Hengrui Pharmaceutical Osteoarthritis Pain Drugs Product
Table 172. Hengrui Pharmaceutical Recent Developments
Table 173. Osteoarthritis Pain Drugs Production Capacity (M Dose) of Key Manufacturers in United States Market, 2019-2021 (M Dose)
Table 174. United States Osteoarthritis Pain Drugs Capacity Market Share of Key Manufacturers, 2019-2021
Table 175. Osteoarthritis Pain Drugs Market Opportunities & Trends in United States Market
Table 176. Osteoarthritis Pain Drugs Market Drivers in United States Market
Table 177. Osteoarthritis Pain Drugs Market Restraints in United States Market
Table 178. Osteoarthritis Pain Drugs Raw Materials
Table 179. Osteoarthritis Pain Drugs Raw Materials Suppliers in United States Market
Table 180. Typical Osteoarthritis Pain Drugs Downstream
Table 181. Osteoarthritis Pain Drugs Downstream Clients in United States Market
Table 182. Osteoarthritis Pain Drugs Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Osteoarthritis Pain Drugs Product Picture
Figure 2. Osteoarthritis Pain Drugs Segment by Type
Figure 3. Osteoarthritis Pain Drugs Segment by Application
Figure 4. United States Osteoarthritis Pain Drugs Market Overview: 2020
Figure 5. United States Osteoarthritis Pain Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Osteoarthritis Pain Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. Osteoarthritis Pain Drugs Sales in United States Market: 2016-2027 (M Dose)
Figure 8. The Top 3 and 5 Players Market Share by Osteoarthritis Pain Drugs Revenue in 2020
Figure 9. Oral Product Picture
Figure 10. Injection Product Picture
Figure 11. External Product Picture
Figure 12. By Type - United States Osteoarthritis Pain Drugs Sales Market Share, 2016-2027
Figure 13. By Type - United States Osteoarthritis Pain Drugs Revenue Market Share, 2016-2027
Figure 14. By Type - United States Osteoarthritis Pain Drugs Price (US$/Dose), 2016-2027
Figure 15. Medical Care
Figure 16. Personal Care
Figure 17. By Application - United States Osteoarthritis Pain Drugs Sales Market Share, 2016-2027
Figure 18. By Application - United States Osteoarthritis Pain Drugs Revenue Market Share, 2016-2027
Figure 19. By Application - United States Osteoarthritis Pain Drugs Price (US$/Dose), 2016-2027
Figure 20. Pfizer Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Bayer Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. SK Chemicals Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. GSK Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Sanofi Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Crystal Genomics Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Johnson & Johnson Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Sino Biopharmaceutical Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Haohai Biological Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Freda Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Bright Future Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Chugai Pharmaceutical Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. Mikasa Seiyaku Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. Taisho Pharmaceutical Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 36. Seikagaku Corporation Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 37. GlaxoSmithKline Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Eli Lilly Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Novartis Osteoarthritis Pain Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Horizon Pharma Osteoarthritis Pain Drugs Revenu

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Sodium Hyaluronate Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 97

Hyaluronic acid (HA) is a naturally occurring polymer found throughout The body. HA is vital for maintaining The function of healthy tissue, and can be used for a variety of applications.In this report we include Hyaluronic Acid Sodium Injection for Beauty industry and Therapy. The global Sodium Hyaluronate market was valued at US$ 357 million in 2023 and is anticipated to reach US$ 1237.4 million by 2030, witnessing a CAGR of 19.2% during The forecast period 2024-2030. Globa......

Global Sodium Hyaluronate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116

According to our LPI (LP Information) latest study, the global Sodium Hyaluronate market size was valued at US$ 349.2 million in 2023. With growing demand in downstream market, the Sodium Hyaluronate is forecast to a readjusted size of US$ 1245.4 million by 2030 with a CAGR of 19.9% during review period. The research report highlights the growth potential of the global Sodium Hyaluronate market. Sodium Hyaluronate are expected to show stable growth in the future market. However, product ......

Global Osteoarthritis Pain Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 149

According to our LPI (LP Information) latest study, the global Osteoarthritis Pain Drugs market size was valued at US$ 9601.5 million in 2023. With growing demand in downstream market, the Osteoarthritis Pain Drugs is forecast to a readjusted size of US$ 14350 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Osteoarthritis Pain Drugs market. Osteoarthritis Pain Drugs are expected to show stable growth in the futur......

Global Sodium Hyaluronate Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 112

According to our (Global Info Research) latest study, the global Sodium Hyaluronate market size was valued at USD 367.3 million in 2023 and is forecast to a readjusted size of USD 1196.4 million by 2030 with a CAGR of 18.4% during review period. Hyaluronic acid (HA) is a naturally occurring polymer found throughout the body. HA is vital for maintaining the function of healthy tissue, and can be used for a variety of applications.In this report we include Hyaluronic Acid Sodium Injection ......

Global Rheumatoid Arthritis Drug Professional Survey Report 2023, Forecast to 2028

Published: 22-Dec-2023        Price: US 3280 Onwards        Pages: 105

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

Global Rheumatoid Arthritis Drug Market Research Report 2023, Forecast to 2028

Published: 22-Dec-2023        Price: US 2680 Onwards        Pages: 162

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

Global Sulfasalazine Market Research Report 2023, Forecast to 2028

Published: 28-Nov-2023        Price: US 2680 Onwards        Pages: 165

Sulfasalazine (SSZ), sold under the trade name Azulfidine among others, is a medication used to treat rheumatoid arthritis, ulcerative colitis, and Crohn's disease. It is considered by some to be a first-line treatment in rheumatoid arthritis. It is taken by mouth. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segme......

Global Sulfasalazine Professional Survey Report 2023, Forecast to 2028

Published: 28-Nov-2023        Price: US 3280 Onwards        Pages: 131

Sulfasalazine (SSZ), sold under the trade name Azulfidine among others, is a medication used to treat rheumatoid arthritis, ulcerative colitis, and Crohn's disease. It is considered by some to be a first-line treatment in rheumatoid arthritis. It is taken by mouth. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segme......

Global Osteoarthritis Pain Drugs Market Research Report 2023, Forecast to 2028

Published: 20-Nov-2023        Price: US 2680 Onwards        Pages: 158

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs